Upgrade to SI Premium - Free Trial

Biogen to acquire Apellis Pharmaceuticals for $5.6 billion or $41/sh plus CVR

March 31, 2026 6:45 AM
(Updated - March 31, 2026 6:50 AM EDT)

Biogen Inc. (NASDAQ: BIIB) has agreed to acquire Apellis Pharmaceuticals Inc ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Hot Corp. News Hot M&A Mergers and Acquisitions Trader Talk

Next Articles